Efficacy of Mesalamine in Irritable Bowel Syndrome
Clinical Gastroenterology and Hepatology · 2023
DOI: 10.1016/j.cgh.2023.03.021 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023. Verfasst von Cong Dai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China. Hauptthemen laut MEDLINE: Mesalamine, Irritable Bowel Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.
Zitieren
APA
Dai, C., Jiang, M., & Huang, Y. H. (2023). Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.03.021
Vancouver
Dai C, Jiang M, Huang YH. Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. 2023. doi:10.1016/j.cgh.2023.03.021
BibTeX
@article{Dai2023,
author = {Dai, Cong and Jiang, Min and Huang, Yu-Hong},
title = {Efficacy of Mesalamine in Irritable Bowel Syndrome},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
doi = {10.1016/j.cgh.2023.03.021}
}
EUVIMED